W1RB34 Stock Overview
An insurance holding company, operates as a commercial lines writers worldwide. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
W. R. Berkley Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$35.16 |
52 Week High | US$35.16 |
52 Week Low | US$20.87 |
Beta | 0.62 |
11 Month Change | 5.78% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | 74.71% |
5 Year Change | n/a |
Change since IPO | 127.69% |
Recent News & Updates
Recent updates
Shareholder Returns
W1RB34 | BR Insurance | BR Market | |
---|---|---|---|
7D | 0.8% | -1.4% | -0.06% |
1Y | n/a | 16.2% | -1.6% |
Return vs Industry: Insufficient data to determine how W1RB34 performed against the BR Insurance industry.
Return vs Market: Insufficient data to determine how W1RB34 performed against the BR Market.
Price Volatility
W1RB34 volatility | |
---|---|
W1RB34 Average Weekly Movement | n/a |
Insurance Industry Average Movement | 3.0% |
Market Average Movement | 4.5% |
10% most volatile stocks in BR Market | 8.5% |
10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: W1RB34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine W1RB34's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1967 | 8,329 | Rob Berkley | www.berkley.com |
W. R. Berkley Corporation, an insurance holding company, operates as a commercial lines writers worldwide. It operates in two segments, Insurance and Reinsurance & Monoline Excess. The Insurance segment underwrites commercial insurance business, including excess and surplus lines, admitted lines, and specialty personal lines.
W. R. Berkley Corporation Fundamentals Summary
W1RB34 fundamental statistics | |
---|---|
Market cap | R$134.16b |
Earnings (TTM) | R$9.14b |
Revenue (TTM) | R$76.46b |
14.7x
P/E Ratio1.8x
P/S RatioIs W1RB34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
W1RB34 income statement (TTM) | |
---|---|
Revenue | US$13.19b |
Cost of Revenue | US$7.42b |
Gross Profit | US$5.78b |
Other Expenses | US$4.20b |
Earnings | US$1.58b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 4.14 |
Gross Margin | 43.78% |
Net Profit Margin | 11.96% |
Debt/Equity Ratio | 33.6% |
How did W1RB34 perform over the long term?
See historical performance and comparison